These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 9182242)
1. Alkylation of [3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus. Nénonéné EK; Radja F; Carli M; van Gelder NM; Afkhami-Dastjerdian S; Reader TA Neurochem Res; 1996 Feb; 21(2):167-76. PubMed ID: 9182242 [TBL] [Abstract][Full Text] [Related]
2. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors. Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924 [TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin. Nénonéné EK; Radja F; Carli M; Grondin L; Reader TA J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133 [TBL] [Abstract][Full Text] [Related]
4. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates. Alper RH; Nelson DL Eur J Pharmacol; 2000 Feb; 390(1-2):67-73. PubMed ID: 10708708 [TBL] [Abstract][Full Text] [Related]
5. Regional heterogeneity of serotonin(1A) receptor inactivation and turnover in the aging female rat brain following EEDQ. Keck BJ; Lakoski JM Neuropharmacology; 2000 Apr; 39(7):1237-46. PubMed ID: 10760365 [TBL] [Abstract][Full Text] [Related]
6. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Meller E; Goldstein M; Bohmaker K Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223 [TBL] [Abstract][Full Text] [Related]
7. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents. Hall MD; Gozlan H; Emerit MB; el Mestikawy S; Pichat L; Hamon M Neurochem Res; 1986 Jun; 11(6):891-912. PubMed ID: 3016581 [TBL] [Abstract][Full Text] [Related]
9. [(3)H]-8-OH-DPAT binding in the rat brain raphe area: involvement of 5-HT(1A) and non-5-HT(1A) receptors. Assié MB; Koek W Br J Pharmacol; 2000 Jul; 130(6):1348-52. PubMed ID: 10903975 [TBL] [Abstract][Full Text] [Related]
10. [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline. Carli M; Afkhami-Dastjerdian S; Reader TA J Psychiatry Neurosci; 1996 Mar; 21(2):114-22. PubMed ID: 8820177 [TBL] [Abstract][Full Text] [Related]
11. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency. Meller E; Li H; Carr KD; Hiller JM J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306 [TBL] [Abstract][Full Text] [Related]
12. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists. Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290 [TBL] [Abstract][Full Text] [Related]
13. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes. Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779 [TBL] [Abstract][Full Text] [Related]
14. Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivation in regions of rat brain. Vinod KY; Subhash MN; Srinivas BN Neurochem Res; 2001 Feb; 26(2):113-20. PubMed ID: 11478737 [TBL] [Abstract][Full Text] [Related]
15. Effects of a chronic lithium treatment on cortical serotonin uptake sites and 5-HT1A receptors. Carli M; Afkhami-Dastjerdian S; Reader TA Neurochem Res; 1997 Apr; 22(4):427-35. PubMed ID: 9130253 [TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Levant B Brain Res; 1995 Nov; 698(1-2):146-54. PubMed ID: 8581473 [TBL] [Abstract][Full Text] [Related]
17. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor. Emerit MB; Miquel MC; Gozlan H; Hamon M J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520 [TBL] [Abstract][Full Text] [Related]
18. 5-HT(1A) receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems. Watson J; Collin L; Ho M; Riley G; Scott C; Selkirk JV; Price GW Br J Pharmacol; 2000 Jul; 130(5):1108-14. PubMed ID: 10882396 [TBL] [Abstract][Full Text] [Related]
19. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes. Yocca FD; Iben L; Meller E Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034 [TBL] [Abstract][Full Text] [Related]
20. [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum. Alexander BS; Wood MD J Pharm Pharmacol; 1988 Dec; 40(12):888-91. PubMed ID: 2907586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]